1. Home
  2. SITC vs MGTX Comparison

SITC vs MGTX Comparison

Compare SITC & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SITC
  • MGTX
  • Stock Information
  • Founded
  • SITC 1965
  • MGTX 2015
  • Country
  • SITC United States
  • MGTX United States
  • Employees
  • SITC N/A
  • MGTX N/A
  • Industry
  • SITC Real Estate Investment Trusts
  • MGTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SITC Real Estate
  • MGTX Health Care
  • Exchange
  • SITC Nasdaq
  • MGTX Nasdaq
  • Market Cap
  • SITC 600.0M
  • MGTX 670.2M
  • IPO Year
  • SITC 1993
  • MGTX N/A
  • Fundamental
  • Price
  • SITC $12.21
  • MGTX $7.83
  • Analyst Decision
  • SITC Hold
  • MGTX Strong Buy
  • Analyst Count
  • SITC 8
  • MGTX 2
  • Target Price
  • SITC $35.25
  • MGTX $24.00
  • AVG Volume (30 Days)
  • SITC 1.1M
  • MGTX 522.1K
  • Earning Date
  • SITC 08-05-2025
  • MGTX 08-14-2025
  • Dividend Yield
  • SITC 38.97%
  • MGTX N/A
  • EPS Growth
  • SITC N/A
  • MGTX N/A
  • EPS
  • SITC 6.74
  • MGTX N/A
  • Revenue
  • SITC $173,351,000.00
  • MGTX $37,917,000.00
  • Revenue This Year
  • SITC N/A
  • MGTX $145.67
  • Revenue Next Year
  • SITC $5.90
  • MGTX $167.61
  • P/E Ratio
  • SITC $1.70
  • MGTX N/A
  • Revenue Growth
  • SITC N/A
  • MGTX 366.84
  • 52 Week Low
  • SITC $10.46
  • MGTX $3.85
  • 52 Week High
  • SITC $18.15
  • MGTX $8.98
  • Technical
  • Relative Strength Index (RSI)
  • SITC 63.23
  • MGTX 49.11
  • Support Level
  • SITC $11.39
  • MGTX $7.43
  • Resistance Level
  • SITC $12.06
  • MGTX $8.63
  • Average True Range (ATR)
  • SITC 0.28
  • MGTX 0.45
  • MACD
  • SITC 0.10
  • MGTX -0.06
  • Stochastic Oscillator
  • SITC 99.54
  • MGTX 40.89

About SITC SITE Centers Corp.

SITE Centers Corp is a self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing and managing shopping centers.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Share on Social Networks: